The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

33 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Synthesis and biological evaluation of thiazole derivatives as novel USP7 inhibitors.EBI
China Pharmaceutical University
Inhibiting the deubiquitinating enzymes (DUBs).EBI
Genentech
X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human coronavirus papain-like proteases.EBI
Purdue University
Spongiacidin C, a pyrrole alkaloid from the marine sponge Stylissa massa, functions as a USP7 inhibitor.EBI
Kumamoto University
Selective Dual Inhibitors of the Cancer-Related Deubiquitylating Proteases USP7 and USP47.EBI
TBA
Triazole-fused pyrimidines in target-based anticancer drug discovery.EBI
Zhenzhou University
Covalent Small Molecule Immunomodulators Targeting the Protease Active Site.EBI
National Cancer Institute
Blocking Non-enzymatic Functions by PROTAC-Mediated Targeted Protein Degradation.EBI
Second Military Medical University (Naval Medical University)
Recent advances in the development of ubiquitin-specific-processing protease 7 (USP7) inhibitors.EBI
Zhengzhou University
Structure-Activity Relationship of USP5 Inhibitors.EBI
University of Toronto
A perspective on medicinal chemistry approaches towards adenomatous polyposis coli and Wnt signal based colorectal cancer inhibitors.EBI
Gitam (Deemed To Be University)
Discovery of Orally Bioavailable EBI
China Pharmaceutical University
Discovery of Potent Small-Molecule USP8 Inhibitors for the Treatment of Breast Cancer through Regulating ERα Expression.EBI
China Pharmaceutical University
Discovery of Potent OTUB1/USP8 Dual Inhibitors Targeting Proteostasis in Non-Small-Cell Lung Cancer.EBI
Fudan University
Design, synthesis, biological evaluation and structure-activity relationship study of quinazolin-4(3H)-one derivatives as novel USP7 inhibitors.EBI
Zhengzhou University
Discovery of USP7 small-molecule allosteric inhibitors.EBI
Medivir
N-benzylpiperidinol derivatives as novel USP7 inhibitors: Structure-activity relationships and X-ray crystallographic studies.EBI
China Pharmaceutical University
Discovery of Potent, Selective, and Orally Bioavailable Inhibitors of USP7 with In Vivo Antitumor Activity.EBI
Rapt Therapeutics
Advances in Discovering Deubiquitinating Enzyme (DUB) Inhibitors.EBI
Dana-Farber Cancer Institute
Identification and Structure-Guided Development of Pyrimidinone Based USP7 Inhibitors.EBI
Almac Discovery
Sulawesins A-C, Furanosesterterpene Tetronic Acids That Inhibit USP7, from a Psammocinia sp. Marine Sponge.EBI
Kumamoto University
Pyrrolo[2,1-f][1,2,4]triazines: From C-nucleosides to kinases and back again, the remarkable journey of a versatile nitrogen heterocycle.EBI
Teva Global R&D
Chemical Approaches to Intervening in Ubiquitin Specific Protease 7 (USP7) Function for Oncology and Immune Oncology Therapies.EBI
Progenra
Discovery of Small-Molecule Inhibitors of Ubiquitin Specific Protease 7 (USP7) Using Integrated NMR and in Silico Techniques.EBI
Genentech
Solid forms of an HPK1 inhibitorBDB
Incyte
Curcumin analogues as zinc chelators and their usesBDB
The Research Foundation For The State University of New York
Inhibitors of fibroblast activation proteinBDB
Praxis Biotech
Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitorsBDB
Incyte
Substituted [1,2,4]triazolo[1,5-a]pyrazines as LSD1 inhibitorsBDB
Incyte
1-pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of SHP2BDB
Novartis
Fused heterocyclic ring compounds and method of treating retinal disease using sameBDB
The Industry & Academic Cooperation In Chungnam National University (IAC)
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors.BDB
University of Lubeck